Value Bridge — HOLMES REGL MEDICAL CENTER
Current $2M → Target $15M (+$13.1M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$1.5M
Current EBITDA
$14.6M
Target EBITDA
+$13.1M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.0M
Payer Mix Optimization
$7.1M
Cost to Collect Reduction
$2.4M
Clean Claim Improvement
$1.8M
Volume & Rate Growth
$11.9M
What This Means
The 7-lever model projects a 850% EBITDA uplift from $2M to $15M. The highest-impact lever is Volume & Rate Growth at $4.7M probability-weighted.
IC talking point: "We see $13M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $144M in equity value creation."